Sessions on:

Acute Stroke: February 16, 2009

Finding and treating the penumbra / Future trials and clinical decisions based on
DEFUSE and EPITHET results - Jeffrey L. Saver

Is CTA/CTP ready for prime time?

rt-PA: history of development, FDA approval, & subsequent quagmires - Justin Zivin

Current update on acute trials: IMS III, Fast Mag, MR RESCUE, TNK - Steven Levine

Debate/Panel: What is the current best diagnostic paradigm for acute stroke?
Louis Caplan / Jeffrey L. Saver / David Tanne / Steven Levine

What is the current treatment of ICH in light of recent trial results?



Prevention: February 17, 2009

What to do after a TIA? - Louis Caplan

Overview and optimizing stroke prevention strategies - David Tanne

Debate/Panel: Medical vs. interventional management of intracranial stenosis -
Louis Caplan / David Tanne

Ongoing stroke prevention trials - Nathan Bornstein

Evidence-based guidelines to prevent complications after stroke

Rehabilitation

Role of functional MRI in understanding mechanisms of brain recovery

Evidence-based guidelines for the post-stroke patient's recovery

Current clinical trials in stroke rehabilitation



Experimental: February 16, 2009

New approaches to acute stroke treatment - Justin Zivin



Infections of the Nervous System: February 17, 2009
Parallel Sessions - Israel Steiner, Chairman

PML - Joe Berger

Lyme disease - Andy Pachner

Post infectious CNS disorders - Israel Steiner

The role of viral infection in Guillain Barre syndrome - Itzik Wirguin

Controversies in bacterial meningitis: when to do an LP, when to use steroids etc.

The possible viral etiology of MS



Epilepsy: February 16, 2009
Parallel Sessions - Ilan Blatt, Chairman

Meet the Professors: breakout sessions / workshops
Bring challenging cases to and hear challenging cases from the Professors